Chronic Chlamydia pneumoniae infection is a risk factor for the development of COPD

被引:27
作者
Brandén, E
Koyi, H
Gnarpe, J
Gnarpe, H
Tornling, G
机构
[1] Karolinska Inst, Div Resp Med, Dept Med, S-17176 Stockholm, Sweden
[2] Univ Alberta, Dept Med Microbiol & Immunol, Edmonton, AB B6G 2H7, Canada
[3] Uppsala Univ, Inst Med Sci, S-75185 Uppsala, Sweden
[4] AstraZeneca R&D, S-22100 Lund, Sweden
关键词
Chlamydia pneumoniae; chronic obstructive pulmonary disease; spirometry;
D O I
10.1016/j.rmed.2004.04.014
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Smoking is the major risk factor for the development of Chronic Obstructive Pulmonary Disease (COPD), but epidemiological data suggest that other etiological factors may also be involved. Chlamydia pneumoniae (Cpn) is an established cause of acute and chronic upper and lower respiratory tract infections. Data obtained from in vitro and in vivo studies indicate that Cpn infection can be involved in the development of both small airways disease and emphysema, the two major components of COPD. The aim of this study was to investigate the possible association between chronic Cpn infection and COPD. The study population was comprised of 199 consecutive patients who underwent bronchoscopy due to longstanding airway symptoms and for whom spirometry and serum samples for serology were available. Acute and convalescent sera were analysed for specific IgG and IgA Cpn antibodies using microimmunoftuorescence. Chronic Cpn infection, defined as persistent elevated titres of IgAgreater than or equal to1/64, was present in 85 patients. Chronic infection was associated with smoking and higher age, but no gender difference was observed. Thirty patients had COPD, defined as FEV1/FVC <70% without any features of asthma. Patients with COPD were older than those without, and there was no association with gender in this group. A statistically significant association, remaining after correction for smoking, was observed between chronic Cpn infection and COPD, and there was a trend for decreasing lung function with increasing antibody titres. The results suggest that chronic Cpn infection may be an independent risk factor for the development of COPD. (C) 2004 Elsevier Ltd. Alt rights reserved.
引用
收藏
页码:20 / 26
页数:7
相关论文
共 37 条
  • [1] [Anonymous], 1987, AM REV RESPIR DIS, V136, P225
  • [2] EFFECTS OF SMOKING INTERVENTION AND THE USE OF AN INHALED ANTICHOLINERGIC BRONCHODILATOR ON THE RATE OF DECLINE OF FEV(1) - THE LUNG HEALTH STUDY
    ANTHONISEN, NR
    CONNETT, JE
    KILEY, JP
    ALTOSE, MD
    BAILEY, WC
    BUIST, AS
    CONWAY, WA
    ENRIGHT, PL
    KANNER, RE
    OHARA, P
    OWENS, GR
    SCANLON, PD
    TASHKIN, DP
    WISE, RA
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1994, 272 (19): : 1497 - 1505
  • [3] Medical progress: Chronic obstructive pulmonary disease.
    Barnes, PJ
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (04) : 269 - 280
  • [4] Beatty Wandy L., 1994, Trends in Microbiology, V2, P94, DOI 10.1016/0966-842X(94)90542-8
  • [5] BERGLUND E, 1963, ACTA MED SCAND, V173, P185
  • [6] BLASI F, 1993, EUR RESPIR J, V6, P19
  • [7] DETECTION OF CHLAMYDIA-PNEUMONIAE BY POLYMERASE CHAIN-REACTION
    CAMPBELL, LA
    MELGOSA, MP
    HAMILTON, DJ
    KUO, CC
    GRAYSTON, JT
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1992, 30 (02) : 434 - 439
  • [8] Standardizing Chlamydia pneumoniae assays:: Recommendations from the Centers for Disease Control and Prevention (USA) and the Laboratory Centre for Disease Control (Canada)
    Dowell, SF
    Peeling, RW
    Boman, J
    Carlone, GM
    Fields, BS
    Guarner, J
    Hammerschlag, MR
    Jackson, LA
    Kuo, CC
    Maass, M
    Messmer, TO
    Talkington, DF
    Tondella, ML
    Zaki, SR
    Bandea, C
    Black, C
    O'Conner, S
    Papp, J
    Perilla, MJ
    Schuchat, A
    Stevens, V
    Van Beneden, CA
    Zell, ER
    Cohen, C
    Campbell, LA
    Wwang, SP
    Grayston, JT
    Deal, CD
    Gaydos, C
    Schindler, L
    Taylor, CE
    Mahony, J
    Fong, IW
    Leinonen, M
    Saikku, P
    Maas, M
    Ossewaarde, JM
    Persson, K
    Boman, J
    Apfalter, P
    [J]. CLINICAL INFECTIOUS DISEASES, 2001, 33 (04) : 492 - 502
  • [9] Comparison of individuals with and without specific IgA antibodies to Chlamydia pneumoniae -: Respiratory morbidity and the metabolic syndrome
    Falck, C
    Gnarpe, J
    Hansson, LO
    Svärdsudd, K
    Gnarpe, H
    [J]. CHEST, 2002, 122 (05) : 1587 - 1593
  • [10] CHLAMYDIA-PNEUMONIAE (TWAR) - A COMMON AGENT IN ACUTE BRONCHITIS
    FALCK, G
    HEYMAN, L
    GNARPE, J
    GNARPE, H
    [J]. SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 1994, 26 (02) : 179 - 187